文献速递神经重症与神经感染

去骨瓣减压术与标准内科治疗创伤性颅内高压患者24个月结局评估:RESCUEicp随机临床试验的二次分析

Evaluation of Outcomes Among Patients With Traumatic Intracranial Hypertension Treated With Decompressive Craniectomy vs Standard Medical Care at 24 Months: A Secondary Analysis of the RESCUEicp Randomized Clinical Trial.
PubMed 文献 · JAMA Neurol · 2022-01-01

RESCUEicp试验的预设二次分析,纳入20国52中心408例创伤性颅内高压(>25 mm Hg)患者,随机分入手术组206例与内科组202例。24个月时手术组死亡率降低(33.5% vs 54.0%,绝对差-20.5,95%CI -30.8至-10.2),但植物状态、严重残疾和中等残疾率高于内科组;两组良好恢复率相似(11.0% vs 10.9%)。手术组6至24个月净改善(≥1级)更常见(30.0% vs 14.0%,χ²₂=13.27,P=.001)。

要点

  • 24个月手术组死亡率33.5% vs 内科组54.0%,绝对差-20.5(95%CI -30.8至-10.2)。
  • 手术组植物状态绝对差4.3(95%CI 0.0至8.6),严重残疾和中等残疾率亦高于内科组。
  • 每100例手术患者24个月多存活21例,其中植物状态4例、严重残疾9例、中等残疾8例。

核心结论

  • 24个月时,手术治疗的创伤性难治性颅内高压患者死亡率持续降低,但植物状态、严重残疾和中等残疾率更高。
  • 手术组患者较内科组更可能随时间改善。

研究设计与样本

  • RESCUEicp随机临床试验数据的预设二次分析,纳入20国52中心创伤性颅内高压(>25 mm Hg)患者408例,手术组206例、内科组202例。
  • 纳入标准为年龄10至65岁、经CT确认的创伤性脑损伤、颅内压监测、尽管采取控压措施仍持续难治性颅内压升高1至12小时。
  • 排除标准为双侧瞳孔固定散大、出血素质或不可存活损伤。
  • 患者按1:1随机接受去骨瓣减压术联合标准治疗(手术组)或持续内科治疗并可选加用巴比妥输注(内科组)。
  • 入组时间为2004年1月至2014年3月,数据分析于2018年至2021年进行。

主要发现

  • 24个月时手术组死亡率33.5%(61例)vs 内科组54.0%(94例),绝对差-20.5(95%CI -30.8至-10.2)。
  • 手术组植物状态绝对差4.3(95%CI 0.0至8.6),严重残疾绝对差2.2(95%CI -5.4至9.8)vs 6.5(95%CI 1.8至11.2),中等残疾绝对差4.7(95%CI -0.9至10.3)vs 2.8(95%CI -4.2至9.8),χ²₇=24.20,P=.001。
  • 每100例手术患者24个月多存活21例,其中植物状态4例、下严重残疾2例、上严重残疾7例、下中等残疾5例、上中等残疾3例。
  • 手术组与内科组下良好恢复和上良好恢复率相似(11.0%[20例] vs 10.9%[19例])。
  • 6至24个月净改善(≥1级)手术组30.0%(55例)vs 内科组14.0%(25例),χ²₂=13.27,P=.001。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Trials often assess primary outcomes of traumatic brain injury at 6 months. Longer-term data are needed to assess outcomes for patients receiving surgical vs medical treatment for traumatic intracranial hypertension. OBJECTIVE: To evaluate 24-month outcomes for patients with traumatic intracranial hypertension treated with decompressive craniectomy or standard medical care. DESIGN, SETTING, AND PARTICIPANTS: Prespecified secondary analysis of the Randomized Evaluation of Surgery With Craniectomy for Uncontrollable Elevation of Intracranial Pressure (RESCUEicp) randomized clinical trial data was performed for patients with traumatic intracranial hypertension (>25 mm Hg) from 52 centers in 20 countries. Enrollment occurred between January 2004 and March 2014. Data were analyzed between 2018 and 2021. Eligibility criteria were age 10 to 65 years, traumatic brain injury (confirmed via computed tomography), intracranial pressure monitoring, and sustained and refractory elevated intracranial pressure for 1 to 12 hours despite pressure-controlling measures. Exclusion criteria were bilateral fixed and dilated pupils, bleeding diathesis, or unsurvivable injury. INTERVENTIONS: Patients were randomly assigned 1:1 to receive a decompressive craniectomy with standard care (surgical group) or to ongoing medical treatment with the option to add barbiturate infusion (medical group). MAIN OUTCOMES AND MEASURES: The primary outcome was measured with the 8-point Extended Glasgow Outcome Scale (1 indicates death and 8 denotes upper good recovery), and the 6- to 24-month outcome trajectory was examined. RESULTS: This study enrolled 408 patients: 206 in the surgical group and 202 in the medical group. The mean (SD) age was 32.3 (13.2) and 34.8 (13.7) years, respectively, and the study population was predominantly male (165 [81.7%] and 156 [80.0%], respectively). At 24 months, patients in the surgical group had reduced mortality (61 [33.5%] vs 94 [54.0%]; absolute difference, -20.5 [95% CI, -30.8 to -10.2]) and higher rates of vegetative state (absolute difference, 4.3 [95% CI, 0.0 to 8.6]), lower or upper moderate disability (4.7 [-0.9 to 10.3] vs 2.8 [-4.2 to 9.8]), and lower or upper severe disability (2.2 [-5.4 to 9.8] vs 6.5 [1.8 to 11.2]; χ27 = 24.20, P = .001). For every 100 individuals treated surgically, 21 additional patients survived at 24 months; 4 were in a vegetative state, 2 had lower and 7 had upper severe disability, and 5 had lower and 3 had upper moderate disability, respectively. Rates of lower and upper good recovery were similar for the surgical and medical groups (20 [11.0%] vs 19 [10.9%]), and significant differences in net improvement (≥1 grade) were observed between 6 and 24 months (55 [30.0%] vs 25 [14.0%]; χ22 = 13.27, P = .001). CONCLUSIONS AND RELEVANCE: At 24 months, patients with surgically treated posttraumatic refractory intracranial hypertension had a sustained reduction in mortality and higher rates of vegetative state, severe disability, and moderate disability. Patients in the surgical group were more likely to improve over time vs patients in the medical group. TRIAL REGISTRATION: ISRCTN Identifier: 66202560.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Kolias AG, Adams H, Timofeev IS, et al. Evaluation of Outcomes Among Patients With Traumatic Intracranial Hypertension Treated With Decompressive Craniectomy vs Standard Medical Care at 24 Months: A Secondary Analysis of the RESCUEicp Randomized Clinical Trial. JAMA Neurol. 2022. PMID: 35666526. doi:10.1001/jamaneurol.2022.1070

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。